ENTRY       D05768                      Drug
NAME        Rotigotine (JAN/USAN/INN);
            Neupro (TN)
PRODUCT     NEUPRO (UCB)
FORMULA     C19H25NOS
EXACT_MASS  315.1657
MOL_WEIGHT  315.4729
CLASS       Neuropsychiatric agent
             DG01472  Dopamine agonist
              DG01468  Dopamine D2-receptor agonist
             DG01967  Antiparkinson agent
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01639  CYP2C19 substrate
             DG02971  SULT substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
              DG03187  UGT2B15 substrate
REMARK      Therapeutic category: 1169 1190
            ATC code: N04BC09
            Product: D05768<JP/US>
EFFICACY    Antiparkinsonian, Dopamine D2 receptor agonist
  DISEASE   Parkinson disease [DS:H00057]
            Restless legs syndrome [DS:H01597]
COMMENT     Treatment of early and advanced Parkinson's disease and restless legs syndrome
TARGET      DRD2 [HSA:1813] [KO:K04145]
  PATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction
            hsa04728(1813)  Dopaminergic synapse
            hsa05012(1813)  Parkinson disease
METABOLISM  Enzyme: SULT [HSA:6817 6799 6818 6783], UGT1A9 [HSA:54600], UGT2B15 [HSA:7366], CYP2C19 [HSA:1557], CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07057  Antiparkinsonian agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BC Dopamine agonists
                 N04BC09 Rotigotine
                  D05768  Rotigotine (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiparkinson Agents
              Dopamine Agonists
               Rotigotine
                D05768  Rotigotine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D05768  Rotigotine (JAN/USAN/INN)
               119  Miscellaneous
                1190  Miscellaneous
                 D05768  Rotigotine (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01472  Dopamine agonist
               DG01468  Dopamine D2-receptor agonist
                D05768  Rotigotine
              DG01967  Antiparkinson agent
               D05768  Rotigotine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D05768  Rotigotine
              DG01639  CYP2C19 substrate
               D05768  Rotigotine
              DG02971  SULT substrate
               D05768  Rotigotine
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                D05768  Rotigotine
               DG03187  UGT2B15 substrate
                D05768  Rotigotine
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D05768  Rotigotine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D05768  Rotigotine (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05768
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05768
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05768
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05768
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D05768
DBLINKS     CAS: 99755-59-6
            PubChem: 47207429
            PDB-CCD: R5F
            LigandBox: D05768
            NIKKAJI: J285.097D
ATOM        22
            1   C8x C    26.0995  -16.8025
            2   C8x C    26.0995  -18.2078
            3   C8y C    27.3165  -18.9104
            4   C8y C    28.5336  -18.2078
            5   C8y C    28.5336  -16.8025
            6   C8x C    27.3165  -16.0998
            7   C1x C    29.7506  -18.9104
            8   C1x C    30.9676  -18.2078
            9   C1y C    30.9676  -16.8025
            10  C1x C    29.7506  -16.0998
            11  N1c N    32.1697  -16.1083
            12  O1a O    27.3165  -20.3155
            13  C1b C    33.3625  -16.7970
            14  C1b C    32.1698  -14.6948
            15  C1b C    33.3662  -14.0039
            16  C1a C    34.5560  -14.6908
            17  C1b C    34.5578  -16.1067
            18  C8y C    35.7519  -16.7961
            19  C8x C    35.8030  -18.2026
            20  C8x C    37.1574  -18.5894
            21  C8x C    37.9438  -17.4208
            22  S2x S    37.0754  -16.3117
BOND        24
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1 #Up
            13    3  12 1
            14   11  13 1
            15   11  14 1
            16   14  15 1
            17   15  16 1
            18   13  17 1
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   21  22 1
            24   18  22 1
///
